Not logged in.png)
Share.png)
SaveIntraspecific competition drives recruit mortality in alpine treelines
Zheng, Xiangyu; Camarero, J. Julio; Sigdel, Shalik Ram; Gao, Shan; Lu, Xiaoming; Li, Xiaoxia; Wu, Tong; Shi, Zheng; Zhu, Haifeng; Liang, Eryuan Share Save Share Save Share Save Share Save Share Save Share Save Share Save Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trialWeathers, Shiao-Pei; Li, Xiqi; Zhu, Haifeng; Damania, Ashish V.; Knafl, Mark; Mckinley, Brian; Lin, Heather; Harrison, Rebecca A.; Majd, Nazanin K.; O'Brien, Barbara J.; Penas-Prado, Marta; Loghin, Monica; Kamiya-Matsuoka, Carlos; Yung, W. K. Alfred; Soto, Luisa M. Solis; Maru, Dipen M.; Wistuba, Ignacio; Parra Cuentas, Edwin R.; Hernandez, Sharia; Futreal, Andrew; Wargo, Jennifer A.; Schulze, Katja; Darbonne, Walter C.; Ajami, Nadim J.; Woodman, Scott E.; de Groot, John F. Share Save Share Save Share Save Share Save Share Save Share Save Biomarkers associated with survival benefit to atezolizumab and bevacizumab for treatment of metastatic anal cancerMorris, V.; Zhu, H.; Li, X.; Johnson, B.; Prasad, S.; Mahvash, A.; Sun, B.; Gite, S.; Panduregan, R.; Parra, E.; Knafl, M.; Woodman, S.; Eng, C.; Halperin, D. Share Save High-Performance Multi-Dynamic Bond Cross-Linked Hydrogel with Spatiotemporal siRNA Delivery for Gene-Cell Combination Therapy of Intervertebral Disc DegenerationChen, Jiaxin; Zhu, Haifeng; Xia, Jiechao; Zhu, Yutao; Xia, Chen; Hu, Zehui; Jin, Yang; Wang, Ji; He, Yong; Dai, Jiayong; Hu, Zhijun Share Save Efficacy, safety, and biomarker analysis of combined MEK (Cobimetinib) and PD-L1 (Atezolizumab) inhibition (COTEZO) in advanced small bowel adenocarcinoma (SBA)Hornstein, Nicholas; Shen, John P.; Pellatt, Andrew J.; Liu, Suyu; Knafl, Mark; Willett, Anneleis F.; Zhu, Haifeng; Maru, Dipen M.; Darbonne, Walter; Wistuba, Ignacio I.; Futreal, Andy; Yao, James C.; Woodman, Scott E.; Overman, Michael J.; Raghav, Kanwal P. Share Save SETD2 loss and ATR inhibition synergistically promote cGAS signaling and immunotherapy response in renal cell carcinomaLiu, Xiande; Zhang, Yanting; Zhang, Xuesong; McGrail, Daniel; Lam, Truong; Hoang, Anh; Hasanov, Elshad; Manyam, Ganiraju; Peterson, Christine B.; Zhu, Haifeng; Kumar, Shwetha V.; Akbani, Rehan; Tannir, Nizar M.; Peng, Guang; Jonasch, Eric Share Save Biomarker analysis: Multi-omics elucidation of Cohort 1 from a phase II study of a triple combination of Atezolizumab plus cobimetinib plus eribulin in patients with metastatic inflammatory breast cancerLim, Bora; Alexander, Angela; Willey, Jie S.; Sun, Huiming; Liu, Suyu; Patel, Anisha B.; Parra, Edwin Roger; Haymaker, Cara; Soto, Luisa Solis; Serrano, Alejandra; Sun, Baohua; Lima, Cibelle Freitas Pinto; Tamegnon, Auriole; Pandurengan, Renganayaki K.; Douse, Dzifa; Lan, Jessica; Raja, Luthra; Chu, Randy; Knafl, Mark; Woodman, Scott E.; Zhu, Haifeng; Shulze, Katja; Fedenko, Katherine; Darbonne, Walter; Ueno, Naoto T.; Valero, Vicente Share Save Multi-modal molecular programs regulate melanoma cell stateAndrews, Miles C.; Oba, Junna; Wu, Chang-Jiun; Zhu, Haifeng; Karpinets, Tatiana; Creasy, Caitlin A.; Forget, Marie-Andree; Yu, Xiaoxing; Song, Xingzhi; Mao, Xizeng; Robertson, A. Gordon; Romano, Gabriele; Li, Peng; Burton, Elizabeth M.; Lu, Yiling; Sloane, Robert Szczepaniak; Wani, Khalida M.; Rai, Kunal; Lazar, Alexander J.; Haydu, Lauren E.; Bustos, Matias A.; Shen, Jianjun; Chen, Yueping; Morgan, Margaret B.; Wargo, Jennifer A.; Kwong, Lawrence N.; Haymaker, Cara L.; Grimm, Elizabeth A.; Hwu, Patrick; Hoon, Dave S. B.; Zhang, Jianhua; Gershenwald, Jeffrey E.; Davies, Michael A.; Futreal, P. Andrew; Bernatchez, Chantale; Woodman, Scott E. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
